Knott David M Jr Cidara Therapeutics, Inc. Transaction History

Knott David M Jr

  • $283 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
BUY
$0.45 - $0.81 $22,847 - $41,126
50,773 Added 7.99%
686,027 $431,000
Q2 2022

Aug 11, 2022
BUY
$0.43 - $0.91 $24,123 - $51,051
56,100 Added 9.69%
635,254 $310,000
Q1 2022

May 16, 2022
BUY
$0.67 - $1.39 $100,672 - $208,858
150,258 Added 35.03%
579,154 $482,000
Q4 2021

Feb 11, 2022
BUY
$1.18 - $2.18 $506,097 - $934,993
428,896 New
428,896 $545,000

Others Institutions Holding CDTX

# of Institutions
52
Shares Held
22.1M
Call Options Held
2.7K
Put Options Held
100
View Full List

About Cidara Therapeutics, Inc.

CDTX Quotes by TradingView
  • Ticker CDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,075,696
  • Market Cap $889M
  • Description
  • Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...
More about CDTX
Track This Portfolio

Track Knott David M Jr Portfolio

Follow Knott David M Jr and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Knott David M Jr, based on Form 13F filings with the SEC.

News

Stay updated on Knott David M Jr with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email